First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

BACKGROUND. The Breast DX Italy prospective study evaluated the impact of the 21‐gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer. MATERIALS AND METHODS. Nine centers (two Hub and seven Spoke centers of the Veneto Oncology Network) participated....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Dieci, Maria Vittoria, Guarneri, Valentina, Giarratano, Tommaso, Mion, Marta, Tortora, Giampaolo, De Rossi, Costanza, Gori, Stefania, Oliani, Cristina, Merlini, Laura, Pasini, Felice, Bonciarelli, Giorgio, Griguolo, Gaia, Orvieto, Enrico, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2017
Matèries:
Breast Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905682/
https://ncbi.nlm.nih.gov/pubmed/29133514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars